RT Journal Article
SR Electronic
T1 Dynamic establishment and maintenance of the human intestinal B cell population and repertoire following transplantation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.15.23298517
DO 10.1101/2023.11.15.23298517
A1 Fu, Jianing
A1 Hsiao, Thomas
A1 Waffarn, Elizabeth
A1 Meng, Wenzhao
A1 Long, Katherine D.
A1 Frangaj, Kristjana
A1 Jones, Rebecca
A1 Gorur, Alaka
A1 Shtewe, Areen
A1 Li, Muyang
A1 Muntnich, Constanza Bay
A1 Rogers, Kortney
A1 Jiao, Wenyu
A1 Velasco, Monica
A1 Matsumoto, Rei
A1 Kubota, Masaru
A1 Wells, Steven
A1 Danzl, Nichole
A1 Ravella, Shilpa
A1 Iuga, Alina
A1 Vasilescu, Elena-Rodica
A1 Griesemer, Adam
A1 Weiner, Joshua
A1 Farber, Donna L.
A1 Luning Prak, Eline T.
A1 Martinez, Mercedes
A1 Kato, Tomoaki
A1 Hershberg, Uri
A1 Sykes, Megan
YR 2023
UL http://medrxiv.org/content/early/2023/11/16/2023.11.15.23298517.abstract
AB It is unknown how intestinal B cell populations and B cell receptor (BCR) repertoires are established and maintained over time in humans. Following intestinal transplantation (ITx), surveillance ileal mucosal biopsies provide a unique opportunity to map the dynamic establishment of gut lymphocyte populations. Using polychromatic flow cytometry that includes HLA allele group-specific mAbs distinguishing donor from recipient cells along with high throughput BCR sequencing, we tracked the establishment of recipient B cell populations and BCR repertoire in the allograft mucosa of ITx recipients. We confirm the early presence of naïve donor B cells in the circulation and, for the first time, document the establishment of recipient B cell populations, including B resident memory cells, in the intestinal allograft mucosa. Recipient B cell repopulation of the allograft was most rapid in infant (<1 year old)-derived allografts and, unlike T cell repopulation, did not correlate with rejection rates. While recipient memory B cell populations were increased in graft mucosa compared to circulation, naïve recipient B cells remained detectable in the graft mucosa for years. Comparisons of peripheral and intra-mucosal B cell repertoires in the absence of rejection revealed increased BCR mutation rates and clonal expansion in graft mucosa compared to circulating B cells, but these parameters did not increase markedly after the first year post-transplant. Furthermore, clonal mixing between the allograft mucosa and the circulation was significantly greater in ITx recipients, even years after transplantation, than in healthy control adults. Collectively, our data demonstrate intestinal mucosal B cell repertoire establishment from a circulating pool, a process that continues for years without evidence of establishment of a stable mucosal B cell repertoire.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study is part of Program Project Grant (PPG) P01 AI106697 funded by the National Institute of Allergy and Infectious Diseases (NIAID). J.F. was supported by Nelson Faculty Development Awards from the Nelson Family Transplantation Innovation Award Program at Columbia University Irving Medical Center. E.W. was supported by NIAID training grant T32AI148099. T.H., A.S. and U.H. were also supported by the European Union's Horizon 2020 Research and Innovation Program under grant agreement 825821 and by Israel Science Foundation (ISF) grant 1327/22. Research reported here was performed in the CCTI Flow Cytometry Core, supported in part by the Office of the Director, National Institutes of Health (NIH) awards S10RR027050 and S10OD020056 and in the Human Immunology Core at the University of Pennsylvania (RRID: SCR 022380), supported in part by NIH awards P30-AI045008 and P30-CA016520.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of the Trustees Of Columbia University In The City Of New York gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. https://github.com/DrexelSystemsImmunologyLab/Pediatric_gut_homeostatsis_paper https://github.com/DrexelSystemsImmunologyLab/clumpiness https://github.com/DrexelSystemsImmunologyLab/diversity